Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial

BM Eyck, JJB van Lanschot, MCCM Hulshof… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Preoperative chemoradiotherapy according to the chemoradiotherapy for esophageal
cancer followed by surgery study (CROSS) has become a standard of care for patients …

[HTML][HTML] Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant …

BM Eyck, BJ van der Wilk, BJ Noordman… - Trials, 2021 - Springer
Background The Surgery As Needed for Oesophageal cancer (SANO) trial compares active
surveillance with standard oesophagectomy for patients with a clinically complete response (…

Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis

BM Eyck, BD Onstenk, BJ Noordman, D Nieboer… - Annals of …, 2020 - journals.lww.com
Objective: The aim of this study was to perform a meta-analysis on the accuracy of endoscopic
biopsies, EUS, and 18F-FDG PET (-CT) for detecting residual disease after neoadjuvant …

Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group

BJ van der Wilk, ERC Hagens, BM Eyck… - British Journal of …, 2022 - academic.oup.com
Background Large studies comparing totally minimally invasive oesophagectomy (TMIE)
with laparoscopically assisted (hybrid) oesophagectomy are lacking. Although randomized …

Chemoradiotherapy followed by active surveillance versus standard esophagectomy for esophageal cancer: a systematic review and individual patient data meta …

BJ Van Der Wilk, BM Eyck, WL Hofstetter… - Annals of …, 2022 - journals.lww.com
Objective: To compare overall survival of patients with a cCR undergoing active surveillance
versus standard esophagectomy. Summary of Background Data: One-third of patients with …

[HTML][HTML] Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective …

X Zhang, BM Eyck, Y Yang, J Liu, YK Chao, MM Hou… - Bmc Cancer, 2020 - Springer
Background After neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, high
pathologically complete response (pCR) rates are being achieved especially in patients with …

[HTML][HTML] Lasting symptoms and long-term health-related quality of life after totally minimally invasive, hybrid and open Ivor Lewis esophagectomy

BM Eyck, F Klevebro, BJ Van der Wilk, A Johar… - European Journal of …, 2022 - Elsevier
Aim Compared to open esophagectomy (OE), both totally minimally invasive (TMIE) and
laparoscopy-assisted hybrid minimally invasive (HMIE) reduce postoperative morbidity and …

Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer

BM Eyck, MPHM Jansen, BJ Noordman… - The Journal of …, 2023 - Wiley Online Library
Active surveillance instead of standard surgery after neoadjuvant chemoradiotherapy (nCRT)
has been proposed for patients with oesophageal cancer. Circulating tumour DNA (ctDNA) …

Towards an organ-sparing approach for locally advanced esophageal cancer

BJ Van Der Wilk, BM Eyck, MCW Spaander… - Digestive …, 2019 - karger.com
Background: Active surveillance after neoadjuvant therapies has emerged among several
malignancies. During active surveillance, frequent assessments are performed to detect …

[HTML][HTML] Characteristics predicting short-term and long-term health-related quality of life in patients with esophageal cancer after neoadjuvant chemoradiotherapy and …

BJ van der Wilk, BM Eyck, BJ Noordman… - Annals of Surgical …, 2023 - Springer
Background Esophagectomy is associated with lasting effect on health-related quality of life
(HRQOL). Patients desire detailed information on the expected impact of treatment on their …